CAS レジストリサービス
主要な創薬サービスでワークフローを最適化
効率的な創薬には、完全に統合された強力なデータソースが不可欠です。新しいCAS BioFinder Discovery Platform™などのCASソリューションを利用し、より深い洞察をこれまで以上に迅速に解き明かします。
Address critical risks at every stage of drug discovery
From target validation to lead optimization, our solutions work together to streamline drug discovery while minimizing risk.
Identify high-value targets by exploring curated disease, biomarker, and protein information with CAS BioFinder.
Refine leads with SAR insights, predictive bioactivity models, and MMPA visualizations using CAS BioFinder.
Break down your data silos and reveal pipeline insights by partnering with data experts through CAS Custom Services.
Develop synthesis plans and find suppliers that meet your needs with CAS SciFinder.
Stop making critical decisions with incomplete information
Drug discovery requires comprehensive biological, clinical, toxicological, and chemical data in one place. CAS unifies the key insights your team needs to innovate quickly.
- Unify cross-functional data from chemistry, biology, and clinical research into one connected environment.
- Enable flexible discovery with AI-ready data that integrates seamlessly into your analytics and workflows.
- Minimize guesswork with trustworthy insights powered by the CAS Content Collection™.
See how our life sciences data is built for your team’s success.
The current state of drug discovery: Is there a better way forward?
Time constraints force drug discovery scientists to choose between thoroughness and speed. Our white paper examines how teams are overcoming these challenges to innovate better and faster.
Read the white paper
Frequently asked questions
How does CAS support the drug discovery workflow?
What ROI can I expect from using CAS BioFinder in my drug discovery workflow?
Can CAS BioFinder reduce the risk of late-stage drug failure?
How does CAS help with drug discovery R&D?
Related articles
Is your pharmaceutical product development taking too long?
How can prioritizing data accelerate drug discovery?
